AJP - Endo Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (September 4, 2007). doi:10.1152/ajpendo.00133.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/E1358    most recent
00133.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoy, A. J.
Right arrow Articles by Kraegen, E. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoy, A. J.
Right arrow Articles by Kraegen, E. W
Submitted on February 27, 2007
Accepted on August 27, 2007

Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation

Andrew James Hoy1, Clinton Robert Bruce2, Anna Cederberg1, Nigel Turner3, David E. James4, Gregory James Cooney5, and Edward W Kraegen6*

1 Diabetes and Obesity Research Program, Garvan Insititute of Medical Research, Darlinghurst, New South Wales, Australia
2 Diabetes and Obesity Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
3 Diabetes and Obesity Research Program, Garvan Insitute of Medical Research, Darlinghurst, New South Wales, Australia; School of Health Sciences, University of Wollongong, Wollongong, New South Wales, Australia
4 Diabetes and Metabolism Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia; School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, New South Wales, Australia
5 Diabetes and Obesity Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Sydney, New South Wales, 2010, Australia; St. Vincent's Hospital Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
6 Diabetes and Obesity Research Program, Garvan Insititute of Medical Research, Darlinghurst, New South Wales, Australia; St. Vincent's Hospital Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia

* To whom correspondence should be addressed. E-mail: e.kraegen{at}garvan.org.au.

Hyperglycemia is a defining feature of type 1 and 2 diabetes. Hyperglycemia also causes insulin resistance and we have recently demonstrated that hyperglycemia generated by glucose infusion results in insulin resistance after 5h but not after 3h. The aim of this study was to investigate possible mechanism(s) by which glucose infusion causes insulin resistance in skeletal muscle, and in particular to examine whether this was associated with changes in insulin signaling. Hyperglycemia (~10mM) was produced in cannulated male Wistar rats for up to 5h. The glucose infusion rate required to maintain this hyperglycemia progressively lessened over 5h (by 25%, P < 0.0001 at 5h) without any alteration in plasma insulin levels consistent with the development of insulin resistance. Muscle glucose uptake in vivo (44%, P < 0.05) and glycogen synthesis rate (52%, P < 0.001) were reduced after 5h compared with 3h infusion. Despite these changes there was no decrease in the phosphorylation state of multiple insulin signaling intermediates (IR, Akt, AS160, GSK3{beta}) over the same time course. In isolated soleus strips taken from control, 1h or 5h glucose infused animals, insulin stimulated 2-deoxyglucose transport was similar, but glycogen synthesis was significantly reduced in the 5h muscle sample (68% vs 1h sample, P < 0.001). These results suggest that the reduced muscle glucose uptake in rats after 5h of acute hyperglycemia is due more to the metabolic effects of excess glycogen storage than a defect in insulin signaling or glucose transport.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Alkhateeb, A. Chabowski, J. F. C. Glatz, B. Gurd, J. J. F. P. Luiken, and A. Bonen
Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1056 - E1066.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. J. Winnick, Z. An, M. C. Moore, C. J. Ramnanan, B. Farmer, M. Shiota, and A. D. Cherrington
A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin
Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E358 - E366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. J. Hoy, A. E. Brandon, N. Turner, M. J. Watt, C. R. Bruce, G. J. Cooney, and E. W. Kraegen
Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation
Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E67 - E75.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.